Current and historical daily PE Ratio for Tibet Aim Pharm Inc (
) from 2016 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tibet Aim Pharm stock (SZSE:002826) PE ratio as of Sep 22 2024 is 34.82.
More Details
Tibet Aim Pharm Inc (SZSE:002826) PE Ratio (TTM) Chart
Tibet Aim Pharm Inc (SZSE:002826) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1208
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Tibet Aim Pharm PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-22 | 34.8 | 2024-07-18 | 36.4 |
| 2024-09-20 | 34.8 | 2024-07-17 | 35.8 |
| 2024-09-19 | 35.7 | 2024-07-16 | 35.4 |
| 2024-09-18 | 34.4 | 2024-07-15 | 35.5 |
| 2024-09-13 | 35.5 | 2024-07-12 | 36.8 |
| 2024-09-12 | 36.1 | 2024-07-11 | 36.6 |
| 2024-09-11 | 36.3 | 2024-07-10 | 35.0 |
| 2024-09-10 | 36.8 | 2024-07-09 | 35.5 |
| 2024-09-09 | 36.8 | 2024-07-08 | 35.3 |
| 2024-09-06 | 36.6 | 2024-07-05 | 36.3 |
| 2024-09-05 | 37.3 | 2024-07-04 | 34.8 |
| 2024-09-04 | 36.1 | 2024-07-03 | 36.5 |
| 2024-09-03 | 36.6 | 2024-07-02 | 37.0 |
| 2024-09-02 | 36.7 | 2024-07-01 | 36.5 |
| 2024-08-30 | 37.5 | 2024-06-28 | 36.0 |
| 2024-08-29 | 36.6 | 2024-06-27 | 41.3 |
| 2024-08-28 | 36.5 | 2024-06-26 | 41.6 |
| 2024-08-27 | 36.0 | 2024-06-25 | 40.0 |
| 2024-08-26 | 35.8 | 2024-06-24 | 39.5 |
| 2024-08-23 | 35.0 | 2024-06-21 | 41.6 |
| 2024-08-22 | 35.8 | 2024-06-20 | 41.2 |
| 2024-08-21 | 36.5 | 2024-06-19 | 42.6 |
| 2024-08-20 | 36.5 | 2024-06-18 | 42.4 |
| 2024-08-19 | 37.7 | 2024-06-17 | 41.9 |
| 2024-08-16 | 38.8 | 2024-06-14 | 43.0 |
| 2024-08-15 | 39.0 | 2024-06-13 | 43.4 |
| 2024-08-14 | 39.0 | 2024-06-12 | 44.0 |
| 2024-08-13 | 39.6 | 2024-06-11 | 42.8 |
| 2024-08-12 | 39.1 | 2024-06-07 | 44.0 |
| 2024-08-09 | 38.4 | 2024-06-06 | 41.3 |
| 2024-08-08 | 38.7 | 2024-06-05 | 43.2 |
| 2024-08-07 | 38.8 | 2024-06-04 | 44.7 |
| 2024-08-06 | 39.2 | 2024-06-03 | 45.9 |
| 2024-08-05 | 37.5 | 2024-05-31 | 46.8 |
| 2024-08-02 | 38.5 | 2024-05-30 | 46.4 |
| 2024-08-01 | 38.3 | 2024-05-29 | 47.0 |
| 2024-07-31 | 37.6 | 2024-05-28 | 46.5 |
| 2024-07-30 | 36.6 | 2024-05-27 | 47.7 |
| 2024-07-29 | 37.0 | 2024-05-24 | 47.2 |
| 2024-07-26 | 37.2 | 2024-05-23 | 47.2 |
| 2024-07-25 | 36.5 | 2024-05-22 | 48.8 |
| 2024-07-24 | 36.3 | 2024-05-21 | 49.1 |
| 2024-07-23 | 37.0 | 2024-05-20 | 49.6 |
| 2024-07-22 | 37.5 | 2024-05-17 | 48.8 |
| 2024-07-19 | 36.5 | 2024-05-16 | 49.0 |
Tibet Aim Pharm Inc (SZSE:002826) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Tibet Aim Pharm Inc
ISIN : CNE100002C39
Share Class Description:
SZSE:002826: ACompare
Compare
Traded in other countries / regions
002826.China IPO Date
2016-12-09Description
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers